Literature DB >> 7429634

Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

I Azuma, K I Kamisango, I Saiki, Y Tanio, S Kobayashi, Y Yamamura.   

Abstract

The adjuvant activity of 23 kinds of synthetic N-acetyl muramyl dipeptide analogs on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-l-tyrosine was examined in guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429634      PMCID: PMC551258          DOI: 10.1128/iai.29.3.1193-1196.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers.

Authors:  A Adam; M Devys; V Souvannavong; P Lefrancier; J Choay; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

2.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

3.  Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).

Authors:  F Audibert; L Chedid; P Lefrancier; J Choay; E Lederer
Journal:  Ann Immunol (Paris)       Date:  1977 Apr-Jun

4.  Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; T Shimono; K Harada; T Shiba
Journal:  Biken J       Date:  1976-03

5.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

6.  Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

Authors:  I Azuma; K Sugimura; T Taniyama; M Yamawaki; Y Yamamura
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.

Authors:  A Tanaka; R Saito; K Sugiyama; I Morisaki; S Kotani
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.

Authors:  S Kotani; Y Watanabe; F Kinoshita; I Morisaki; K Kato
Journal:  Biken J       Date:  1977-06

9.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06

10.  In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.

Authors:  C Damais; M Parant; L Chedid; P Lefrancier; J Choay
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

View more
  11 in total

1.  The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. III. Eradication of disseminated murine chronic leukemia cells by utilizing MDP hapten-reactive helper T-cell activity.

Authors:  J Shima; T Yoshioka; H Nakajima; H Fujiwara; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

2.  Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; M Kiso; A Hasegawa; Y Tanio; Y Yamamura
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

3.  Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; Y Tanio; M Kiso; A Hasegawa; Y Yamamura
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

4.  Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.

Authors:  I Saiki; Y Tanio; M Yamawaki; M Uemiya; S Kobayashi; T Fukuda; H Yukimasa; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

5.  Uveitis induction in the rabbit by muramyl dipeptides.

Authors:  R V Waters; T G Terrell; G H Jones
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

6.  Cross-reactivity between haptenic muramyl di- or tripeptide derivatives and Mycobacterium bovis BCG: potential application for enhancing tumor immunity.

Authors:  A Kosugi; J Shima; H Sano; M Ogata; T Kusama; H Fujiwara; T Hamaoka
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.

Authors:  K Matsumoto; H Ogawa; T Kusama; O Nagase; N Sawaki; M Inage; S Kusumoto; T Shiba; I Azuma
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

8.  Stimulation of chemiluminescence by synthetic muramyl dipeptide and analogs.

Authors:  K N Masihi; I Azuma; W Brehmer; W Lange
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.

Authors:  K Nishimura; H Okumura; I Saiki; H Okuyama; I Azuma
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

10.  Synthetic immunomodulators for prevention of fatal infections in a burned guinea pig model.

Authors:  J D Stinnett; L D Loose; P Miskell; C L Tenney; S J Gonce; J W Alexander
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.